These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 11484873

  • 1. Positive correlation between circulating leptin levels and lipid lipoproteins in postmenopausal women administered hormone replacement therapy.
    Kanda T, Ichikawa S, Sumino H, Sakamaki T, Nakamura T, Tsukui S, Nara M, Kobayashi I, Tamura J.
    Res Commun Mol Pathol Pharmacol; 2000; 107(3-4):179-85. PubMed ID: 11484873
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
    Nickelsen T, Creatsas G, Rechberger T, Depypere H, Erenus M, Quail D, Arndt T, Bonnar J, Euralox 1 Study Group.
    Climacteric; 2001 Dec; 4(4):320-31. PubMed ID: 11770189
    [Abstract] [Full Text] [Related]

  • 5. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
    Odmark IS, Bäckström T, Haeger M, Jonsson B, Bixo M.
    Maturitas; 2004 Jun 15; 48(2):137-46. PubMed ID: 15172088
    [Abstract] [Full Text] [Related]

  • 6. Changes in the lipoprotein profile in postmenopausal women receiving hormone replacement therapy. Effects of natural and synthetic progesterone.
    Chen FP, Lee N, Soong YK.
    J Reprod Med; 1998 Jul 15; 43(7):568-74. PubMed ID: 9693406
    [Abstract] [Full Text] [Related]

  • 7. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A, Aldemir DA, Bayrak T, Corakçi A, Dursun P.
    Arch Gynecol Obstet; 2006 Aug 15; 274(5):289-96. PubMed ID: 16810536
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women.
    Sutherland WH, Manning PJ, de Jong SA, Allum AR, Jones SD, Williams SM.
    Metabolism; 2001 Mar 15; 50(3):319-24. PubMed ID: 11230785
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. LycoRed as an alternative to hormone replacement therapy in lowering serum lipids and oxidative stress markers: a randomized controlled clinical trial.
    Misra R, Mangi S, Joshi S, Mittal S, Gupta SK, Pandey RM.
    J Obstet Gynaecol Res; 2006 Jun 15; 32(3):299-304. PubMed ID: 16764620
    [Abstract] [Full Text] [Related]

  • 12. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B, Guzic-Salobir B, Sebestjen M, Keber I.
    Menopause; 2006 Jun 15; 13(4):643-50. PubMed ID: 16837886
    [Abstract] [Full Text] [Related]

  • 13. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec 15; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 14. Effects of oral and transdermal hormone replacement therapy on lipoprotein(A) and lipids: a randomized controlled trial.
    Meschia M, Bruschi F, Soma M, Amicarelli F, Paoletti R, Crosignani P.
    Menopause; 1998 Dec 15; 5(3):157-62. PubMed ID: 9774761
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
    Milewicz T, Kostecka A, Rogatko I, Sztefko K, Kwiatkowska-Panek E, Radowick S, Krzysiek J.
    Przegl Lek; 2007 Dec 15; 64(2):65-9. PubMed ID: 17892034
    [Abstract] [Full Text] [Related]

  • 17. The efficacy of dietary intervention alone or combined with hormone replacement therapy in postmenopausal women with hypercholesterolemia in Seoul, Korea.
    Jung K, Kim S, Woo J, Chang Y.
    Eur J Nutr; 2002 Jun 15; 41(3):101-7. PubMed ID: 12111046
    [Abstract] [Full Text] [Related]

  • 18. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
    Pan HA, Wang ST, Chen CH, Pai MC, Wu MH, Huang KE.
    Climacteric; 2002 Sep 15; 5(3):259-65. PubMed ID: 12419084
    [Abstract] [Full Text] [Related]

  • 19. Changes in lipid metabolism in postmenopausal Japanese women using hormone therapy evaluated by capillary isotachophoresis: a pilot study.
    Inoue Y, Zhang B, Sadamori R, Shirota K, Saku K, Kawarabayashi T.
    Menopause; 2008 Sep 15; 15(1):157-63. PubMed ID: 17603392
    [Abstract] [Full Text] [Related]

  • 20. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.
    Balci H, Altunyurt S, Acar B, Fadiloglu M, Kirkali G, Onvural B.
    Maturitas; 2005 Apr 11; 50(4):289-93. PubMed ID: 15780528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.